Fig. 2

Competitive risk analysis for competitive risk endpoint events based on different pSMI tertiles. After controlling for competing risk events, significant differences in the cumulative incidence of cardiovascular mortality among the three groups of pSMI (P < 0.05), no significant differences were observed among the three groups in non-fatal myocardial infarction and unplanned revascularization events (P > 0.05). Competitive risk analysis for the incidence of cardiovascular death (A), nonfatal myocardial infarction (B), and unplanned repeat revascularization (C)